Osteoporosis due to glucocorticoid use in children with chronic illness (Q36287732)

13 August 2017

1 reference

title

Osteoporosis due to glucocorticoid use in children with chronic illness (English)

1 reference

13 August 2017

0 references

Leanne M Ward

1

1 reference

13 August 2017

14 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

64

1 reference

13 August 2017

5

1 reference

13 August 2017

209-221

1 reference

Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density

13 August 2017

1 reference

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Steroid myopathy in connective tissue disease

21 January 2018

1 reference

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

21 January 2018

1 reference

Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.

21 January 2018

1 reference

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

21 January 2018

1 reference

Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000088976

1 reference

13 August 2017

1 reference

PubMed ID

16227699